Sequoia Financial Advisors, LLC

Position in ARGX — Argenx SE

CIK 1599900 Akron, OH

Position in ARGX

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$1,432,020

-$190,172 QoQ

Shares Held

1,961

+1.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Sequoia Financial Advisors, LLC holds $24,441,881 across 36 Biotechnology names. ARGX ranks #6 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	14,898	$6,652,552
2	REGN	Regeneron Pharmaceuticals, Inc.	3,189	$2,463,948
3	FTRE	Fortrea Holdings Inc.	175,917	$1,657,138
4	INCY	Incyte Corp	16,377	$1,541,403
5	ALNY	Alnylam Pharmaceuticals, Inc.	4,560	$1,508,767
6	ARGX	Argenx SE This page	1,961	$1,432,020
7	JAZZ	Jazz Pharmaceuticals plc	4,138	$782,288
8	RPRX	Royalty Pharma plc	15,670	$751,689

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,432,020	1,961	+1.7%	Shares	Sole	2026-04-30
2025-12-31	$1,622,192	1,929	+1.8%	Shares	Sole	2026-02-03
2025-09-30	$1,397,676	1,895	+3.4%	Shares	Sole	2025-10-29
2025-06-30	$1,010,386	1,833	+0.2%	Shares	Sole	2025-07-25
2025-03-31	$1,082,521	1,829	+1.3%	Shares	Sole	2025-04-23
2024-12-31	$1,110,075	1,805	+5.5%	Shares	Sole	2025-08-08
2024-09-30	$927,498	1,711	-0.1%	Shares	Sole	2024-10-21
2024-06-30	$736,658	1,713	+3.1%	Shares	Sole	2024-07-15
2024-03-31	$653,968	1,661	-5.2%	Shares	Sole	2024-04-30
2023-12-31	$666,893	1,753	+0.1%	Shares	Sole	2024-01-26
2023-09-30	$861,335	1,752	+2.7%	Shares	Sole	2023-11-08
2023-06-30	$664,879	1,706	+8.5%	Shares	Sole	2023-08-08
2023-03-31	$585,695	1,572	-0.4%	Shares	Sole	2023-04-25
2022-12-31	$597,793	1,578	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.